Splenectomy for a Splenic Mass: Diagnosis, Stabilization, and Next Steps

Removing the spleen may be diagnostic and therapeutic for selected splenic masses, but imaging cannot reliably determine benign versus malignant disease before pathology.

Splenectomy removes the spleen and mass after the team assesses stability, bleeding, blood counts, coagulation, chest and abdominal findings, and anesthesia risk. The specimen is submitted for histopathology.

The operation can control active or future splenic bleeding, remove the mass, and provide the diagnosis needed for prognosis and any chemotherapy discussion. Emergency and planned cases have different burdens and uncertainty.

A well-defined procedural goal may be diagnosis, local control, restoration of function, prevention of a predictable complication, or comfort. The likely benefit must be weighed against anesthesia, hospitalization, recovery, anatomy, stage, comorbidities, and the family’s goals.

Discuss before the first incision whenever procedure choice, biopsy tract, margins, reconstruction, specialist equipment, staging, pathology handling, or postoperative support could affect later options. Build pain, nutrition, mobility, wound, and emergency plans before discharge.

Splenectomy is established for appropriate splenic masses, but benign and malignant lesions can look similar and outcome depends on pathology and stage. Population statistics cannot diagnose an individual mass before tissue evaluation.

Hemorrhage, transfusion need, anesthesia complications, arrhythmia, pancreatitis, infection, clotting complications, wound problems, and metastatic disease may affect recovery. Collapse, pale gums, distended abdomen, or sudden weakness is an emergency.

Do not change fasting, prescription medicines, anticoagulants, steroids, NSAIDs, supplements, wound care, activity, or feeding instructions without the procedural team. New bleeding, breathing difficulty, collapse, severe pain, repeated vomiting, wound opening, or loss of function needs prompt assessment.